Cargando…
Transferrin: Biology and Use in Receptor-Targeted Nanotherapy of Gliomas
[Image: see text] Gliomas constitute 80% of malignant brain tumors. The survival rate of patients diagnosed with malignant gliomas is only 34.4%, as seen in both adults as well as children. The biggest challenge in treatment of gliomas is the impenetrable blood–brain barrier. With the availability o...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Chemical Society
2021
|
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8028004/ https://www.ncbi.nlm.nih.gov/pubmed/33842744 http://dx.doi.org/10.1021/acsomega.0c05848 |